HEMOLEVEN Uses, Dosage, Side Effects and more
HEMOLEVEN is under investigation in clinical trial NCT01701947 (HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency).
| Trade Name | HEMOLEVEN |
| Generic | Coagulation factor XIa |
| Coagulation factor XIa Other Names | Human coagulation factor XI |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
